Literature DB >> 29634387

"Examining RAS pathway rewiring with a chemically inducible activator of RAS".

John C Rose1, Emily M Dieter1, Daniel Cunningham-Bryant1, Dustin J Maly1,2.   

Abstract

RAS signaling pathways govern diverse cellular processes, are dynamic, and exhibit marked plasticity. Yet, these features also present a considerable obstacle to their study. Here, we report the use of a recently described RAS rheostat, Chemically Inducible Activator of RAS (CIAR), to study two poorly understood phenomena in RAS biology. First, we show that short-term activation of wild type endogenous RAS can desensitize cells to EGF stimulation. Second, we examine the phenomena of paradoxical activation of RAS/ERK signaling by RAF inhibitors. Specifically, we characterize the effects on RAS/ERK signaling kinetics of four RAF inhibitors, which stabilize distinct ATP-binding site conformations. These results demonstrate the utility of CIAR in conducting quantitative studies of complex features of RAS biology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29634387      PMCID: PMC7549627          DOI: 10.1080/21541248.2018.1446697

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  23 in total

1.  Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivo.

Authors:  Michael D Wendt; Wang Shen; Aaron Kunzer; William J McClellan; Milan Bruncko; Thorsten K Oost; Hong Ding; Mary K Joseph; Haichao Zhang; Paul M Nimmer; Shi-Chung Ng; Alexander R Shoemaker; Andrew M Petros; Anatol Oleksijew; Kennan Marsh; Joy Bauch; Tilman Oltersdorf; Barbara A Belli; Darlene Martineau; Stephen W Fesik; Saul H Rosenberg; Steven W Elmore
Journal:  J Med Chem       Date:  2006-02-09       Impact factor: 7.446

2.  Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

Authors:  Marina Konopleva; Rooha Contractor; Twee Tsao; Ismael Samudio; Peter P Ruvolo; Shinichi Kitada; Xingming Deng; Dayong Zhai; Yue-Xi Shi; Thomas Sneed; Monique Verhaegen; Maria Soengas; Vivian R Ruvolo; Teresa McQueen; Wendy D Schober; Julie C Watt; Tilahun Jiffar; Xiaoyang Ling; Frank C Marini; David Harris; Martin Dietrich; Zeev Estrov; James McCubrey; W Stratford May; John C Reed; Michael Andreeff
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

3.  Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity.

Authors:  Zhi-Fu Tao; Lisa Hasvold; Le Wang; Xilu Wang; Andrew M Petros; Chang H Park; Erwin R Boghaert; Nathaniel D Catron; Jun Chen; Peter M Colman; Peter E Czabotar; Kurt Deshayes; Wayne J Fairbrother; John A Flygare; Sarah G Hymowitz; Sha Jin; Russell A Judge; Michael F T Koehler; Peter J Kovar; Guillaume Lessene; Michael J Mitten; Chudi O Ndubaku; Paul Nimmer; Hans E Purkey; Anatol Oleksijew; Darren C Phillips; Brad E Sleebs; Brian J Smith; Morey L Smith; Stephen K Tahir; Keith G Watson; Yu Xiao; John Xue; Haichao Zhang; Kerry Zobel; Saul H Rosenberg; Chris Tse; Joel D Leverson; Steven W Elmore; Andrew J Souers
Journal:  ACS Med Chem Lett       Date:  2014-08-26       Impact factor: 4.345

4.  RAF inhibitors that evade paradoxical MAPK pathway activation.

Authors:  Chao Zhang; Wayne Spevak; Ying Zhang; Elizabeth A Burton; Yan Ma; Gaston Habets; Jiazhong Zhang; Jack Lin; Todd Ewing; Bernice Matusow; Garson Tsang; Adhirai Marimuthu; Hanna Cho; Guoxian Wu; Weiru Wang; Daniel Fong; Hoa Nguyen; Songyuan Shi; Patrick Womack; Marika Nespi; Rafe Shellooe; Heidi Carias; Ben Powell; Emily Light; Laura Sanftner; Jason Walters; James Tsai; Brian L West; Gary Visor; Hamid Rezaei; Paul S Lin; Keith Nolop; Prabha N Ibrahim; Peter Hirth; Gideon Bollag
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

5.  A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo.

Authors:  Alex R Shoemaker; Anatol Oleksijew; Joy Bauch; Barbara A Belli; Tony Borre; Milan Bruncko; Thomas Deckwirth; David J Frost; Ken Jarvis; Mary K Joseph; Kennan Marsh; William McClellan; Hugh Nellans; ShiChung Ng; Paul Nimmer; Jacqueline M O'Connor; Tilman Oltersdorf; Weiguo Qing; Wang Shen; Jason Stavropoulos; Stephen K Tahir; Baole Wang; Robert Warner; Haichao Zhang; Stephen W Fesik; Saul H Rosenberg; Steven W Elmore
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

6.  Chemical genomics identifies small-molecule MCL1 repressors and BCL-xL as a predictor of MCL1 dependency.

Authors:  Guo Wei; Adam A Margolin; Leila Haery; Emily Brown; Lisa Cucolo; Bina Julian; Shyemaa Shehata; Andrew L Kung; Rameen Beroukhim; Todd R Golub
Journal:  Cancer Cell       Date:  2012-04-17       Impact factor: 31.743

Review 7.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

8.  An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling.

Authors:  Zoi Karoulia; Yang Wu; Tamer A Ahmed; Qisheng Xin; Julien Bollard; Clemens Krepler; Xuewei Wu; Chao Zhang; Gideon Bollag; Meenhard Herlyn; James A Fagin; Amaia Lujambio; Evripidis Gavathiotis; Poulikos I Poulikakos
Journal:  Cancer Cell       Date:  2016-08-11       Impact factor: 31.743

9.  Structure-guided design of a selective BCL-X(L) inhibitor.

Authors:  Guillaume Lessene; Peter E Czabotar; Brad E Sleebs; Kerry Zobel; Kym N Lowes; Jerry M Adams; Jonathan B Baell; Peter M Colman; Kurt Deshayes; Wayne J Fairbrother; John A Flygare; Paul Gibbons; Wilhelmus J A Kersten; Sanji Kulasegaram; Rebecca M Moss; John P Parisot; Brian J Smith; Ian P Street; Hong Yang; David C S Huang; Keith G Watson
Journal:  Nat Chem Biol       Date:  2013-04-21       Impact factor: 15.040

10.  Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling.

Authors:  Amy Young; David Lou; Frank McCormick
Journal:  Cancer Discov       Date:  2012-10-25       Impact factor: 39.397

View more
  1 in total

1.  A Chemically Disrupted Proximity System for Controlling Dynamic Cellular Processes.

Authors:  Daniel Cunningham-Bryant; Emily M Dieter; Glenna W Foight; John C Rose; Dana E Loutey; Dustin J Maly
Journal:  J Am Chem Soc       Date:  2019-02-14       Impact factor: 15.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.